The Austrian healthtech start-up specializes in developing AI-powered medical software designed to digitize the patient journey. It uses advanced algorithms and natural language processing to analyze vast amounts of medical data, offering users personalized health insights and guidance. With the new funding XUND plans to further drive its expansion with a strategic focus on its core markets in the DACH region and the UK.
The BRANDL TALOS team consisted of Adrian Zuschmann and Elena Ciresa.
Lead Ventures has been advised by Erdős Partners (Zita Albert; Felícia Kálmán) and Herbst Kinsky Rechtsanwälte (Wolfgang Schwackhöfer; Alexander Lotz).